Created at	Source	Raw Value	Validated value
June 25, 2024, noon	usa	* unable to take po medication. * need for intubation or ecmo. * pregnancy or lactation * known allergic reactions to tazemetostat. * active malignancy (not in remission). * treatment with another investigational drug.	* unable to take po medication. * need for intubation or ecmo. * pregnancy or lactation * known allergic reactions to tazemetostat. * active malignancy (not in remission). * treatment with another investigational drug.
Aug. 25, 2021, 7:30 p.m.	usa	- unable to take po medication. - need for intubation or ecmo. - pregnancy or lactation - known allergic reactions to tazemetostat. - active malignancy (not in remission). - treatment with another investigational drug.	- unable to take po medication. - need for intubation or ecmo. - pregnancy or lactation - known allergic reactions to tazemetostat. - active malignancy (not in remission). - treatment with another investigational drug.